Promoting gene therapy: Expression systems for transgenes and post-transcriptional gene silencing

Hoshang J. Unwalla, John J. Rossi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

In this review, we have discussed expression systems employed for both transgene expression and post-transcriptional gene silencing. Although constitutive expression systems can function well for gene therapy protocols for simple Mendelian disorders, other protocols may require carefully designed systems that either ensure targeting to cells of interest or alternatively, transcription that is tightly regulated and conditionally activated. Indeed, it is of utmost importance to regulate expression of potentially immunogenic proteins, such as those encoded by suicide genes, to limit their immunogenic potential. Meanwhile, RNAi may be employed for therapeutic silencing of aberrant cellular or viral genes, but the potential for off-target effects due to activation of double-stranded RNA response pathways or undesired targeting of partial complementary sequences may necessitate carefully controlled and regulated expression of short hairpin RNAs. As we exhaust the current repertoire of simple promoter systems for transgene expression or for RNAi, we need to develop newer systems that combine the high activity of viral promoters with cell type specificity or conditionally active cis-elements. Novel combinations of promoter elements should be one approach for creating such regulated promoters.

Original languageEnglish
Pages (from-to)71-91
Number of pages21
JournalBiotechnology and Genetic Engineering Reviews
Volume23
StatePublished - Dec 1 2006

Fingerprint

Gene therapy
RNA Interference
Transgenes
Genetic Therapy
Genes
RNA
Gene Expression
Double-Stranded RNA
Viral Genes
Transcription
Suicide
Small Interfering RNA
Chemical activation
Proteins
Therapeutics

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Biology
  • Bioengineering

Cite this

Promoting gene therapy : Expression systems for transgenes and post-transcriptional gene silencing. / Unwalla, Hoshang J.; Rossi, John J.

In: Biotechnology and Genetic Engineering Reviews, Vol. 23, 01.12.2006, p. 71-91.

Research output: Contribution to journalArticle

@article{2ceabf7c9ddd4ef7ae8e27e94eadeb0d,
title = "Promoting gene therapy: Expression systems for transgenes and post-transcriptional gene silencing",
abstract = "In this review, we have discussed expression systems employed for both transgene expression and post-transcriptional gene silencing. Although constitutive expression systems can function well for gene therapy protocols for simple Mendelian disorders, other protocols may require carefully designed systems that either ensure targeting to cells of interest or alternatively, transcription that is tightly regulated and conditionally activated. Indeed, it is of utmost importance to regulate expression of potentially immunogenic proteins, such as those encoded by suicide genes, to limit their immunogenic potential. Meanwhile, RNAi may be employed for therapeutic silencing of aberrant cellular or viral genes, but the potential for off-target effects due to activation of double-stranded RNA response pathways or undesired targeting of partial complementary sequences may necessitate carefully controlled and regulated expression of short hairpin RNAs. As we exhaust the current repertoire of simple promoter systems for transgene expression or for RNAi, we need to develop newer systems that combine the high activity of viral promoters with cell type specificity or conditionally active cis-elements. Novel combinations of promoter elements should be one approach for creating such regulated promoters.",
author = "Unwalla, {Hoshang J.} and Rossi, {John J.}",
year = "2006",
month = "12",
day = "1",
language = "English",
volume = "23",
pages = "71--91",
journal = "Biotechnology and Genetic Engineering Reviews",
issn = "0264-8725",
publisher = "Nottingham University Press",

}

TY - JOUR

T1 - Promoting gene therapy

T2 - Expression systems for transgenes and post-transcriptional gene silencing

AU - Unwalla, Hoshang J.

AU - Rossi, John J.

PY - 2006/12/1

Y1 - 2006/12/1

N2 - In this review, we have discussed expression systems employed for both transgene expression and post-transcriptional gene silencing. Although constitutive expression systems can function well for gene therapy protocols for simple Mendelian disorders, other protocols may require carefully designed systems that either ensure targeting to cells of interest or alternatively, transcription that is tightly regulated and conditionally activated. Indeed, it is of utmost importance to regulate expression of potentially immunogenic proteins, such as those encoded by suicide genes, to limit their immunogenic potential. Meanwhile, RNAi may be employed for therapeutic silencing of aberrant cellular or viral genes, but the potential for off-target effects due to activation of double-stranded RNA response pathways or undesired targeting of partial complementary sequences may necessitate carefully controlled and regulated expression of short hairpin RNAs. As we exhaust the current repertoire of simple promoter systems for transgene expression or for RNAi, we need to develop newer systems that combine the high activity of viral promoters with cell type specificity or conditionally active cis-elements. Novel combinations of promoter elements should be one approach for creating such regulated promoters.

AB - In this review, we have discussed expression systems employed for both transgene expression and post-transcriptional gene silencing. Although constitutive expression systems can function well for gene therapy protocols for simple Mendelian disorders, other protocols may require carefully designed systems that either ensure targeting to cells of interest or alternatively, transcription that is tightly regulated and conditionally activated. Indeed, it is of utmost importance to regulate expression of potentially immunogenic proteins, such as those encoded by suicide genes, to limit their immunogenic potential. Meanwhile, RNAi may be employed for therapeutic silencing of aberrant cellular or viral genes, but the potential for off-target effects due to activation of double-stranded RNA response pathways or undesired targeting of partial complementary sequences may necessitate carefully controlled and regulated expression of short hairpin RNAs. As we exhaust the current repertoire of simple promoter systems for transgene expression or for RNAi, we need to develop newer systems that combine the high activity of viral promoters with cell type specificity or conditionally active cis-elements. Novel combinations of promoter elements should be one approach for creating such regulated promoters.

UR - http://www.scopus.com/inward/record.url?scp=81755162290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81755162290&partnerID=8YFLogxK

M3 - Article

C2 - 22530503

AN - SCOPUS:81755162290

VL - 23

SP - 71

EP - 91

JO - Biotechnology and Genetic Engineering Reviews

JF - Biotechnology and Genetic Engineering Reviews

SN - 0264-8725

ER -